High-throughput (HT) antibody generation platform

Our proprietary live-cell immunization, high-efficient fusion and subcloning technology platforms can effectively generate functional monoclonal antibodies (mAbs) that interact with novel biomarkers or known antigens with high affinity and specificity. In combination with our unique antibody engineering and productional cell-line processing techniques, the antibody drug candidates can be smoothly transferred to downstream production process for preclinical and clinical studies.